BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
5.09
-0.10 (-1.93%)
Oct 24, 2025, 4:00 PM EDT - Market closed
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $9.14 million as of October 27, 2025. Its market cap has increased by 24.13% in one year.
Market Cap
9.14M
Enterprise Value
6.30M
1-Year Change
24.13%
Ranking
Category
Stock Price
$5.09
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $9.14M, a decrease of -78.29%. That is a compound annual growth rate of -25.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 9.14M | 81.96% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 209.13B |
| BHP Group | 142.89B |
| Rio Tinto Group | 120.65B |
| Southern Copper | 105.05B |
| Newmont | 90.98B |
| The Sherwin-Williams Company | 83.04B |
| Agnico Eagle Mines | 82.06B |
| CRH plc | 80.53B |